Titan Spine Receives Regulatory Clearance to Launch Endoskeleton® TAS ALIF Interbody Fusion Device with Integrated Fixation
Unique Implant Incorporates Integrated Screws that Prevent the Need for Supplemental Fixation
MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has received FDA clearance to commercially release its Endoskeleton® TAS system, consisting of an ALIF device with integrated fixation screws. The regulatory clearance is the fifth such approval for the company and supplements its current line of TLIF, PLIF, ALIF, and cervical interbody implants.